Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Del Williams
Options to address the risk of combustible dust explosions for NFPA 61 compliance
Doug Folsom
Unpatched vulnerabilities will become increasingly susceptible to cyberattacks
Del Williams
Mitigate risk, prevent safety issues by utilizing closed conveyor systems designed with sanitation in mind
Dirk Dusharme @ Quality Digest
Companies say they plan to pull some or all of their devices
Dirk Dusharme @ Quality Digest
First step, migrate your QMS to a cloud-based electronic quality management system

More Features

FDA Compliance News
Company’s first funding round will be used to accelerate product development for its QMS and MES SaaS offerings
Showcasing tech, solutions, and services at Gulfood Manufacturing 2022
Easy, reliable leak testing with methylene blue
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community
Good quality is adding an average of 11 percent to organizations’ revenue growth

More News

Quality Digest

FDA Compliance

Rathbun Named SAFE-BioPharma Chief Technology Officer

Published: Wednesday, December 14, 2005 - 22:00

George Rathbun, director of architecture in Pfizer’s Global Research and Development Informatics group, was recently named chief technology officer of SAFE-BioPharma Association. SAFE-BioPharma is the pharmaceutical-industry–sponsored organization that’s developing and managing a secure digital-signature standard for global use throughout the pharmaceutical and health care industries. Rathbun will oversee and administer all aspects of technology for SAFE-BioPharma.

“George Rathbun’s background at Pfizer, knowledge of SAFE, and his broad knowledge of the pharmaceutical industry make him the ideal person to lead SAFE’s technology development and implementation,” says Mollie Shields-Uehling, SAFE-BioPharma president and CEO.

Rathbun joined Pfizer in 1990 and has been its information and technology architect for the past five years. For more information, visit www.safe-biopharma.org.


About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.